Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond D Blind

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|May 20, 2024
X-ray crystallographic analyses of 14 IPMK inhibitor complexesHuanchen Wang, Raymond D Blind, Stephen B Shears
Science Signaling|June 21, 2012
Direct modification and activation of a nuclear receptor-PIP₂ complex by the inositol lipid kinase IPMKRaymond D Blind, Miyuki Suzawa, Holly A Ingraham
Biorxiv : the Preprint Server for Biology|November 24, 2025
Structural rationalization of IPMK inhibitor potencyHuanchen Wang, Stephen B Shears, Raymond D Blind
Journal of Medicinal Chemistry|November 14, 2025
Structural Rationalization of IPMK Inhibitor PotencyHuanchen Wang, Stephen B Shears, Raymond D Blind
Journal of Lipid Research|June 25, 2023
Full-length nuclear receptor allosteric regulationWoong Jae Choi, Zeinab Haratipour, Raymond D Blind
Biorxiv : the Preprint Server for Biology|May 15, 2024
Multiple inositol phosphate species enhance stability of active mTORLucia E Rameh, John D York, Raymond D Blind
Advances in Biological Regulation|November 14, 2016
Phospholipid regulation of the nuclear receptor superfamilyMark K Crowder, Corey D Seacrist, Raymond D Blind
The Journal of Biological Chemistry|December 20, 2024
Inositol phosphates dynamically enhance stability, solubility, and catalytic activity of mTORLucia E Rameh, John D York, Raymond D Blind
Biomolecules|October 28, 2023
SF-1 Induces Nuclear PIP2Ethan S Chi, Elizabeth A Stivison, Raymond D Blind
Biorxiv : the Preprint Server for Biology|June 10, 2024
Bilirubin is a new ligand for nuclear receptor Liver Receptor Homolog-1Pratima Chapagain, Zeinab Haratipour, M Merced Malabanan, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|May 20, 2024
X-ray crystallographic analyses of 14 IPMK inhibitor complexesHuanchen Wang, Raymond D Blind, Stephen B Shears
Science Signaling|June 21, 2012
Direct modification and activation of a nuclear receptor-PIP₂ complex by the inositol lipid kinase IPMKRaymond D Blind, Miyuki Suzawa, Holly A Ingraham
Biorxiv : the Preprint Server for Biology|November 24, 2025
Structural rationalization of IPMK inhibitor potencyHuanchen Wang, Stephen B Shears, Raymond D Blind
Journal of Medicinal Chemistry|November 14, 2025
Structural Rationalization of IPMK Inhibitor PotencyHuanchen Wang, Stephen B Shears, Raymond D Blind
Journal of Lipid Research|June 25, 2023
Full-length nuclear receptor allosteric regulationWoong Jae Choi, Zeinab Haratipour, Raymond D Blind
Biorxiv : the Preprint Server for Biology|May 15, 2024
Multiple inositol phosphate species enhance stability of active mTORLucia E Rameh, John D York, Raymond D Blind
Advances in Biological Regulation|November 14, 2016
Phospholipid regulation of the nuclear receptor superfamilyMark K Crowder, Corey D Seacrist, Raymond D Blind
The Journal of Biological Chemistry|December 20, 2024
Inositol phosphates dynamically enhance stability, solubility, and catalytic activity of mTORLucia E Rameh, John D York, Raymond D Blind
Biomolecules|October 28, 2023
SF-1 Induces Nuclear PIP2Ethan S Chi, Elizabeth A Stivison, Raymond D Blind
Biorxiv : the Preprint Server for Biology|June 10, 2024
Bilirubin is a new ligand for nuclear receptor Liver Receptor Homolog-1Pratima Chapagain, Zeinab Haratipour, M Merced Malabanan, et al.
Pageof 4